Japan
· Delayed Price · Currency is JPY Carna Biosciences Statistics
Total Valuation
TYO:4572 has a market cap or net worth of JPY 5.35 billion. The enterprise value is 3.30 billion.
| Market Cap | 5.35B |
| Enterprise Value | 3.30B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4572 has 19.10 million shares outstanding. The number of shares has increased by 6.61% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 19.10M |
| Shares Change (YoY) | +6.61% |
| Shares Change (QoQ) | +5.23% |
| Owned by Insiders (%) | 9.87% |
| Owned by Institutions (%) | 0.71% |
| Float | 14.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.41 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.51 |
| EV / Sales | 5.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.38 |
Financial Position
The company has a current ratio of 12.33, with a Debt / Equity ratio of 0.02.
| Current Ratio | 12.33 |
| Quick Ratio | 9.89 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.04 |
| Interest Coverage | -692.00 |
Financial Efficiency
Return on equity (ROE) is -68.60% and return on invested capital (ROIC) is -39.37%.
| Return on Equity (ROE) | -68.60% |
| Return on Assets (ROA) | -36.44% |
| Return on Invested Capital (ROIC) | -39.37% |
| Return on Capital Employed (ROCE) | -81.41% |
| Revenue Per Employee | 10.10M |
| Profits Per Employee | -34.57M |
| Employee Count | 63 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 1.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.65% in the last 52 weeks. The beta is 0.47, so TYO:4572's price volatility has been lower than the market average.
| Beta (5Y) | 0.47 |
| 52-Week Price Change | -33.65% |
| 50-Day Moving Average | 274.56 |
| 200-Day Moving Average | 325.02 |
| Relative Strength Index (RSI) | 56.79 |
| Average Volume (20 Days) | 159,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4572 had revenue of JPY 636.00 million and -2.18 billion in losses. Loss per share was -121.61.
| Revenue | 636.00M |
| Gross Profit | 465.00M |
| Operating Income | -2.08B |
| Pretax Income | -2.17B |
| Net Income | -2.18B |
| EBITDA | -2.05B |
| EBIT | -2.08B |
| Loss Per Share | -121.61 |
Balance Sheet
The company has 2.11 billion in cash and 59.00 million in debt, giving a net cash position of 2.05 billion or 107.30 per share.
| Cash & Cash Equivalents | 2.11B |
| Total Debt | 59.00M |
| Net Cash | 2.05B |
| Net Cash Per Share | 107.30 |
| Equity (Book Value) | 2.47B |
| Book Value Per Share | 129.55 |
| Working Capital | 2.52B |
Cash Flow
In the last 12 months, operating cash flow was -1.37 billion and capital expenditures -13.00 million, giving a free cash flow of -1.39 billion.
| Operating Cash Flow | -1.37B |
| Capital Expenditures | -13.00M |
| Free Cash Flow | -1.39B |
| FCF Per Share | -72.63 |
Margins
| Gross Margin | 73.11% |
| Operating Margin | -326.42% |
| Pretax Margin | -341.82% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4572 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.61% |
| Shareholder Yield | -6.61% |
| Earnings Yield | -40.73% |
| FCF Yield | -25.94% |
Stock Splits
The last stock split was on December 26, 2013. It was a forward split with a ratio of 100.
| Last Split Date | Dec 26, 2013 |
| Split Type | Forward |
| Split Ratio | 100 |
Scores
TYO:4572 has an Altman Z-Score of 10.01.
| Altman Z-Score | 10.01 |
| Piotroski F-Score | n/a |